Your SlideShare is downloading. ×
Novartis & Alcon's takeover
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Introducing the official SlideShare app

Stunning, full-screen experience for iPhone and Android

Text the download link to your phone

Standard text messaging rates apply

Novartis & Alcon's takeover

987
views

Published on

Analysis of Novartis & Alcon's takeover in 2009

Analysis of Novartis & Alcon's takeover in 2009

Published in: Business

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
987
On Slideshare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
25
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Novartis & Alcon
    The takeover
    Jérémie LORRAIN & Kelly BLASCO
  • 2. Introduction
    What is a Takeover?
    Friendly
    Hostile
  • 3. Overview
    Presentation of the companies
    Reasons of the takeover
    Stock Market
    How does Novartis finance it?
  • 4. Novartis
    Swiss pharmaceutical company
    Created in 1996
    2009 turnover: $ 44,3 billion
    Employees: 100 000
  • 5. Alcon
    American pharmaceutical firm
    Founded in 1945 by R.Alexander & W.Coner
    2008 turnover: $ 6 293 billion
    Employees: 15 000
  • 6. Reasons of the takeover
    28 billion dollars
    Strengthen innovation power & diversify its range of medication
    Together they cover more than 70% of the global vision care sector
    Benefice for the shareholders, employees and patients
  • 7. Stock Market - Alcon
    19th February stock price : $ 159.08
    15th March stock price: $162.48
  • 8. Stock Market - Novartis
    • 5thfebruary: Novartis’ shares were worth 57,75 dollars
    • 9. Today: 58,35 dollars
  • How does Novartis finance it?
    $14 billion to be financed
    Strong cash flow
    Mix of bonds and loans
    Selling shares
  • 10. Conclusion
    Future success ?